University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Doctoral Dissertations

Dissertations and Theses

October 2021

Therapist-Level Moderation of Within- and Between-Therapist
Process-Outcome Associations
Alice E. Coyne
University of Massachusetts Amherst

Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2
Part of the Clinical Psychology Commons

Recommended Citation
Coyne, Alice E., "Therapist-Level Moderation of Within- and Between-Therapist Process-Outcome
Associations" (2021). Doctoral Dissertations. 2295.
https://doi.org/10.7275/24226401 https://scholarworks.umass.edu/dissertations_2/2295

This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

Therapist-Level Moderation of Within- and Between-Therapist Process-Outcome Associations

A Dissertation Presented
by
ALICE E. COYNE

Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of

DOCTOR OF PHILOSOPHY
September 2021
Clinical Psychology

© Copyright by Alice E. Coyne 2021
All Rights Reserved

Therapist-Level Moderation of Within- and Between-Therapist Process-Outcome Associations

A Dissertation Presented
by
ALICE E. COYNE

Approved as to style and content by:
_________________________________________________
Michael J. Constantino, Chair

_________________________________________________
Holly B. Laws, Member

_________________________________________________
Christopher R. Martell, Member

_________________________________________________
Linda M. Isbell, Member

_________________________________________________
Sarah A. Fefer, Member

________________________________________
Caren M. Rotello, Department Chair
Department of Psychological and Brain Sciences

DEDICATION

In loving memory of my grandfather, Thomas Glenn Coyne, Sr., who first told me that I would
get a PhD (or two) when I was 5 years old

ACKNOWLEDGMENTS
I am incredibly grateful for the support I have received throughout my graduate career. I
would first like to thank my parents for their endless love, support, and wisdom. I would not have
been able to achieve any of this without you. Thank you both for being endless sources of
strength and encouragement through the many challenges of graduate school. I would also like to
thank my childhood and college friends and extended family for helping me to remember that
there is a life outside of graduate school.
In addition, I would like to thank my graduate school friends and peers. I am especially
grateful to my lab mates: Samantha Bernecker, Nicholas Morrison, Brien Goodwin, Heather
Muir, and Averi Gaines. It has been a truly wonderful experience to be part of such a close-knit,
supportive team. I will always treasure the many late-night or early-morning meetings in the lab
that could have been painful, but that instead were always full of laughter and camaraderie. To
my cohort mate and academic twin, Brien Goodwin, I would like to say a special thank you for
your friendship and support as we went through every step of graduate school together. I cannot
imagine completing this degree without you. In addition, I would like to thank the more advanced
non-lab graduate students who mentored and supported me through this process: Drs. MK
Oakley, Genna Santorelli, and Rachel Herman.
Many teachers and supervisors have inspired and supported me throughout my
undergraduate and graduate careers. In particular, I would like to thank my undergraduate
advisor, Dr. Barbara Keyes, who helped me conduct my first psychotherapy research study. I
would also like to thank Dr. Scott Melzer who gave me my first experiences conducting research.
Although it would be nearly impossible to thank all of the amazing professors who have inspired
and challenged me during graduate school, I am especially grateful to Drs. Aline Sayer and Holly
Laws, who helped me learn the advanced statistics that have enabled me to study the complexities
of psychotherapy. Additionally, I would also like to thank Dr. Laws for the countless hours you
spent helping me develop as a teacher and methodology consultant. I am also particularly grateful

v

to Dr. Christopher Martell whose guidance and supervision helped me develop my own voice as a
clinician and scientist-practitioner.
I am also grateful to the many people who helped me to complete this project. I would
like to thank Drs. Michael Constantino, James Boswell, and David Kraus for allowing this study
to be a small part of the larger Match System trial. I would also like to thank the project
coordinator, Felicia Romano, for her endless hours of work in helping to collect these data.
Additionally, I would like to thank my dissertation committee members, Drs. Holly Laws,
Christopher Martell, Linda Isbell, and Sarah Fefer, for your helpful feedback and willingness to
serve in this role.
Finally, I am incredibly grateful to my advisor and dissertation chair, Dr. Michael
Constantino. Words cannot express how fortunate I feel for having had the chance to work with
such a gifted scientist, teacher, and mentor. Your unwavering support, guidance, and friendship
have been truly invaluable over the last seven years. Thank you for always believing in me as
both a person and a scientist, even, or perhaps especially, in the moments when I did not believe
in myself.

vi

ABSTRACT
THERAPIST-LEVEL MODERATION OF WITHIN- AND BETWEEN-THERAPIST
PROCESS-OUTCOME ASSOCIATIONS
SEPTEMBER 2021
ALICE E. COYNE, B.A., ALBION COLLEGE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Michael J. Constantino

Objective: Although higher-quality patient-therapist alliance and more positive patient outcome
expectation (OE) consistently predict improvement in psychotherapy, most research has failed to
capture the inherent nuance in these process-outcome relations by parsing them into withintherapist (i.e., differences between patients treated by the same therapist) and between-therapist
(i.e., differences between therapists’ average process/outcome ratings across all patients in their
caseloads) components. Moreover, the few studies that have done so have produced mixed
results, suggesting the possibility of systematic variability in these associations (i.e., moderators).
One potential source of such variability could be providers themselves; that is, different therapists
could use these processes to differing therapeutic benefit. In this vein, the present study had three
primary aims. First, I tested the alliance- and OE-outcome associations at both the within- and
between-therapist levels. Second, I examined whether the within-therapist alliance- and OEoutcome associations varied among therapists. Third, I explored therapist-level moderators (i.e.,
theoretical orientation, self-perceived alliance- and OE-strategy usage, and self-perceived
alliance- and OE-fostering effectiveness) of the within- and between-therapist alliance- and OEoutcome associations. Finally, as an ancillary question, I explored whether the two components of
the process-outcomes associations interacted to predict treatment outcomes; namely, does the
extent to which patient-level variability in alliance and OE correlates with improvement (within-
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therapist component) differ as a function of therapists’ general abilities (across all patients) to
foster positive alliances and OE (between-therapist component)? Method: Data derived from 212
adult outpatients treated naturalistically by 42 psychotherapists as part of a randomized trial that
compared different case assignment methods. Patients completed measures of alliance, OE, and
outcome repeatedly throughout treatment, and therapist rated their characteristics at baseline. I
used multilevel structural equation models to test the primary and ancillary research questions.
Results: Regarding aim 1, higher-quality between-therapist alliance was associated with greater
caseload-level improvement (0.62, SD = 0.29; 95% credible interval [CI] = 0.003, 1.10), whereas
within-therapist alliance was unrelated to patient-level improvement (0.38, SD = 0.20; 95% CI = 0.07, 0.75). Although between-therapist OE was unrelated to caseload-level improvement (2.64,
SD = 1.69; 95% CI = -0.67, 6.20), more optimistic OE was associated with greater patient-level
improvement (0.84, SD = 0.35; 95% CI = 0.15, 1.53). Regarding aim 2, both within-therapist
process-outcome associations varied significantly among therapists. Regarding aim 3, therapists’
self-perceived alliance-fostering effectiveness moderated the within-therapist alliance-outcome
association (-0.76, SD = 0.24; 95% CI = -1.18, -0.28), whereas identification with a cognitive
behavioral orientation moderated the between-therapist alliance-outcome association (-0.46, SD =
0.23; 95% CI = -0.96, -0.004). Taken together, the alliance may have stronger within-therapist
associations with improvement in the hands of therapists who are humbler in assessing their own
alliance-fostering abilities, and stronger between-therapist associations with improvement for
therapists who do not identify strongly with a cognitive behavioral orientation. Finally, regarding
the ancillary aim, the within- and between-therapist process components did not have a
significant interactive effect on treatment outcomes. Conclusions. Results indicate that different
therapists use theory-common treatment processes to differing therapeutic benefit, which can
inform more personalized clinical practices and trainings.
Keywords: within- and between-therapist effects, multilevel process-outcome
associations, therapeutic alliance, outcome expectation, therapist-level moderation
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CHAPTER 1
INTRODUCTION
Although psychotherapy is generally efficacious (e.g., Lambert, 2013), it remains that a
substantial number of patients do not benefit. More specifically, evidence indicates that over 40%
of psychotherapy patients do not experience clinically significant improvement across treatment,
whereas another 10-15% reliably deteriorate in their symptoms and functioning (Kraus et al.,
2011; Lambert, 2010). Given these sobering no-change and deterioration rates, researchers have
increasingly attempted to uncover factors that can associate with, and thereby help enhance, the
reach and consistency of psychotherapy’s effectiveness.
To date, the most consistent predictors of positive psychotherapy outcomes have been
process variables (i.e., relational and participant variables that occur within the confines of a
treatment course) that are largely transtheoretical and transdiagnostic, or what have been termed
“common” factors (Norcross & Lambert, 2018). Perhaps the quintessential relational process
factor is the therapeutic alliance, or the emotional and collaborative bond between a patient and
therapist (Bordin, 1979). In the most recent meta-analysis of over 30,000 patients from 295
samples, a higher quality alliance was associated with greater patient improvement across
different treatments and patient diagnoses (d = .58; Flückiger et al., 2018). Similarly, a prominent
patient process factor is outcome expectation (OE), or the belief about the likelihood that one’s
therapy will be effective. In the most recent meta-analysis of over 12,000 patients from 81
samples, more positive early treatment OE was associated with greater patient improvement
across diverse treatments and patient problems (d = .36;1 Constantino et al., 2018). Although
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Although the aggregate effect size for the alliance-outcome association (Flückiger et al., 2018) appears to
be larger than the aggregate OE-outcome association (Constantino et al., 2018), it is worth noting that the
OE meta-analysis only included studies that measured OE early in treatment, whereas the alliance metaanalysis included studies that measured it at any time during treatment (including late phases when a higher
quality alliance may be more confounded with improvement). When the effect size for the early treatment
(sessions 1-5) alliance-improvement association (r = .22) is compared to the very early treatment (pretreatment or session 1) OE-improvement association (r = .18), they are quite similar in size. Thus, it seems
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these findings compellingly demonstrate that alliance and OE bear on psychotherapy outcomes,
their clinical utility is somewhat limited due to a notable methodological issue. Namely, most
research on the alliance and virtually all research on OE has failed to account for the complex
structure of most psychotherapy data, whereby single therapists treat multiple patients (Baldwin
& Imel, 2013). Put simply, as a result of this nesting, all during-therapy processes can be parsed
into patient and therapist contributions, which can have meaningfully different clinical
implications.
The patient component, or what is often termed within-therapist variability, reflects
differences in a given process (e.g., alliance quality, OE) among different patients working with
the same therapist. The therapist component, or what is often termed between-therapist
variability, reflects differences in therapists’ average given process (e.g., alliance quality, OE)
across all patients in their caseloads. Importantly, if within-therapist differences in psychotherapy
processes predict an outcome (e.g., as patients’ alliance scores increase relative to their same
therapist’s average alliance score, it correlates significantly with, say, symptom reduction), it
necessarily points to something about the patient or the individual patient-therapist dyad driving
this effect, but not specifically the person of the therapist who is held constant in this scenario (for
a graphical depiction of this scenario, see Figure 1; Baldwin & Imel, 2013). In contrast, if
between-therapist differences in processes predict an outcome (e.g., as the average patient OE
score that a therapist cultivates across all cases increases, relative to other therapists’ average OE
scores, it correlates significantly with, say, improved functioning), it necessarily points to
something about the therapist (and how they influence all of their therapy relationships) driving
this effect, as opposed to the individual patient or dyad (for a graphical depiction of this scenario,
see Figure 2; Baldwin & Imel, 2013). Of course, both components could uniquely and

reasonable to assume that these two variables both explain meaningful variability in treatment outcomes,
and both should remain a focus of future inquiry.
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simultaneously influence patients’ treatment outcomes, and/or these two components could
interact to predict outcomes (Baldwin & Imel, 2013). Thus, determining whether processoutcome associations operate at the within-therapist level, between-therapist level, at both levels,
or through a complex interaction of the two is necessary for illuminating the precise clinical
meaning of these associations and for understanding the utility of different therapeutic processes.
Yet, as noted, despite the voluminous literature on process-outcome associations (Constantino et
al., in press), relatively few studies have parsed such associations into their patient and therapist
contributions.
Of the rare existing studies that have parsed these components, almost all have focused
on the alliance construct, with somewhat mixed results. On the one hand, some studies have
demonstrated that both within- and between-therapist alliance quality correlated significantly with
patients’ treatment outcomes. For example, in a sample of depressed patients being treated with
cognitive behavioral therapy (CBT), interpersonal psychotherapy, or placebo with clinical
management, higher quality early treatment within- and between-therapist alliances were
associated with faster symptom reduction (Zuroff et al., 2010). Similarly, in a study of CBT for
panic disorder with agoraphobia, greater within-therapist alliance quality was associated with
more anxiety and panic reduction, and greater between-therapist alliance quality was associated
with lower dropout rates (Huppert et al., 2014). Finally, in a sample of adolescents in treatment
for substance use, both within- and between-therapist variability in alliance quality were
positively associated with improvement, as measured by at least some of the included outcome
measures (Marcus et al., 2011).
On the other hand, some studies have demonstrated that only one of the alliance
components correlated significantly with patients’ treatment outcomes. For example, in a large
naturalistic study of varied psychotherapies for diverse presenting problems, greater between-,
but not within-, therapist alliance quality was associated with better average outcomes (Baldwin
et al., 2007). Similarly, in a study comparing motivational enhancement therapy to counseling-as-
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usual for substance use, greater between-, but not within-, therapist alliance quality was
associated with changes in substance use (Crits-Christoph et al., 2009). However, the nature of
this between-therapist association was somewhat unexpected; that is, patients who saw therapists
with very high or very low average alliances across their cases had worse outcomes, whereas
patients who saw therapists with more moderate average alliances had better outcomes. In a study
of cognitive and dynamic therapy for depression, the authors found that greater between-, but not
within-, therapist alliance associated with better outcomes (Crits-Christoph et al., 2018).
Moreover, this study used an instrumental variable approach that allowed the authors to infer
causality in the alliance-outcome link.
In contrast, in a large naturalistic psychotherapy sample, the authors found that greater
within-, but not between-, therapist early treatment alliance quality related to subsequent
improvement (Falkenström et al., 2014). Similarly, in a sample of patients with substance use
disorders receiving various forms of psychotherapy, greater within-, but not between-, therapist
very early (week 1) alliance quality was associated with symptom reduction (Crits-Christoph, et
al., 2011). Finally, in a sample of patients with generalized anxiety disorder (GAD) receiving
various forms of CBT, the authors found that greater within-, but not between-, therapist early
alliance quality (averaged across weeks 1 through 4) was associated with worry and distress
reduction (Coyne et al., 2021).
Taken together, across the nine studies that have parsed the alliance in this manner, three
found evidence for both within- and between-therapist alliance-outcome associations, three found
evidence for only between-therapist alliance-outcome associations, and three found evidence for
only within-therapist alliance-outcome associations. Thus, although existing research rather
evenly supports within- and between-therapist alliance-outcome linkages, the significance of each
component (of the total correlation) is quite variable across studies. Such mixed results may
suggest systematic variability in the size of these parsed associations; that is, there may be
contextual moderators that render one or both of these components more vs. less relevant for
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treatment outcome. Although speculative, it seems plausible that such variability may be due to
differences between providers themselves; similar to patient-level findings that the alliance is
more therapeutic for some patients than others (e.g., Constantino, Coyne et al., 2017; Zack et al.,
2015), it may be that the alliance is more therapeutic in the hands of some therapists than others.
Adding even more complexity, such therapist differences in the alliance-outcome association
could theoretically exist at both levels of analysis.
At the within-therapist level, such variability could mean that even if two patients (treated
by different therapists) both rated their alliance 5 points higher than their therapist’s average
alliance (across all patients they treat), this rating might translate into a 4-point improvement (on
some hypothetical outcome) for Therapist A’s patient and a 10-point improvement for Therapist
B’s patient. At the between-therapist level, such variability could mean that even if Therapist A
and Therapist B both achieved exactly the same average alliance level across all patients in their
caseloads (i.e., they achieved similar relational “climates” across their patients), this might
translate into an 8-point improvement for Therapist A’s average patient’s outcome and a 2-point
improvement for Therapist B’s average patient’s outcome. Thus, if such variability exists at either
(or both) levels, it could be important to uncover the therapist-level characteristics/practices that
set the condition for using the alliance to its fullest therapeutic potential (or, alternatively, for
failing to harness the alliance for therapeutic good).
Notably, some preliminary support exists for this type of therapist-level moderation. For
example, one study found that the size of the within-therapist alliance-outcome association varied
significantly across therapists in a large sample of patients with heterogeneous disorders receiving
various forms of inpatient psychotherapy (Dinger et al., 2008). The authors concluded that for
some therapists, greater alliance quality for individual patients was strongly associated with
improvement for those patients; for other therapists, however, variation in alliance quality was
unrelated to their patients’ outcomes. However, none of the therapist-level variables the authors
investigated (i.e., gender, age, clinical experience) explained for which therapists alliance was
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more (or less) therapeutic. Moreover, although the authors treated the alliance as a patient-level
(within-therapist) variable, they did not fully disaggregate it into its within- and between-therapist
components; that is, alliance quality in this study represented a blend of patient and therapist
contributions, leaving it ambiguous as to which alliance component varied across therapists.
In the only other study of which I am aware that tested this question, in a sample of
patients receiving variants of CBT for GAD, the authors fully disaggregated the alliance-outcome
association and found that the within-therapist alliance-outcome association varied significantly
among therapists (Coyne et al., 2021). Specifically, therapists who were one standard deviation
above the mean had positive alliance-improvement associations that were more than double the
average alliance-improvement association, whereas therapists one standard deviation below the
mean had alliance-improvement associations that were near zero. However, similar to the
previous study on this topic (Dinger et al., 2008), no therapist-level variables accounted for such
between-therapist differences (although in this case, the authors only examined treatment type as
the single putative moderator).2
Although research parsing other (beyond the alliance) process-outcome associations into
their within- and between-therapist components is virtually nonexistent, a few studies have
descriptively examined whether non-alliance processes, like OE, vary at both the patient (withintherapist) and therapist (between-therapist) levels. For example, three studies have found that
therapists account for a significant proportion of the variability in OE (Constantino, Aviram, et
al., 2020; Vîslă et al., 2019; Vîslă et al., in press). Thus, research that accounts for such therapist
contributions by parsing the OE-outcome association into its within- and between-therapist
components is sorely needed. Moreover, as with the alliance construct, it seems plausible that
certain therapists vs. others could harness patient OE to greater therapeutic benefit.

2

Given the specific focus of the Coyne et al. (2021) study, the authors did not test moderators of the
between-therapist alliance-outcome association.
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Stated differently, in addition to continuing to disaggregate process-outcome
associations, it could behoove the psychotherapy research field to search for therapist-level
moderators of within-therapist, and possibly between-therapist, process-outcome associations.
Uncovering such moderators could have meaningful practice and training implications. For
example, regarding training, such knowledge could allow for the development of personalized
therapist trainings tailored to the processes that each therapist is empirically likely to use to
therapeutic effect – a type of “playing to strengths,” or the presence of therapist-level facilitative
factors (Smith-Hansen, 2016). As an example, if research revealed that a particular therapist tends
to use the alliance to achieve positive outcomes (either when the alliance is higher than their own
average, or when compared to other providers), that therapist may be best suited to being trained
on and delivering relationally oriented interventions. Alternatively, knowledge of therapist-level
moderators could direct personalized trainings toward the presence of therapist-level risk factors
– a type of remediation strategy – to have therapists improve their use of more common processes
to therapeutic benefit. Such personalization, in either form, could enhance the effects of clinical
training, which, at present, tend to be unrelated to therapist effectiveness (Tracey et al., 2014).
Underscoring the potential utility of this approach, one researcher reflected on the lack of
significant effects of an alliance-focused training on patient outcomes by noting that such
trainings should be tailored to therapists’ unique styles and approaches (Smith-Hansen, 2016).
Similarly, another researcher noted that different therapists appeared to be differentially able to
benefit from alliance-focused trainings, with some therapists (particularly those who indicated not
typically viewing the alliance as a key change mechanism) becoming less effective following
such training (Crits-Christoph et al., 2010). Thus, research that can aid in personalizing training to
the therapist is sorely needed.
In this vein, the first aim of the present study was to test the alliance- and OE-outcome
associations at both the within- and between-therapist levels in a sample of therapists delivering
naturalistic treatment in a community mental health system. Given the mixed nature of the
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existing alliance literature and the novelty of this question for the OE literature, both of these
analyses were largely exploratory. However, given the well-established total correlations
between these processes and treatment outcomes (Constantino, Vîslă, et al., 2018; Flückiger et
al., 2018), I expected that the association with outcome for both alliance and OE would be
significant for at least one level of analysis. The second aim of this study was to test whether the
size of the within-therapist alliance- and OE-outcome associations varied among therapists.3
Given previous findings on the alliance (Coyne et al., 2021; Dinger et al., 2008), I hypothesized
that the within-therapist alliance-outcome association would show significant between-therapist
variability. Given the lack of such research on OE, this question was exploratory.
The third aim of this study was to explore whether specific therapist-level variables
moderated the within- and between-therapist alliance- and OE-outcome associations. Given the
limited (alliance) or nonexistent (OE) research to date, I drew on theory and findings from related
research areas to select variables that may be the most likely to moderate these associations. First,
although the alliance has been shown to relate to outcome across different treatments, different
theoretical orientations propose different roles for the alliance in treatment (Hatcher & Barends,
2006; Zilcha-Mano, 2017). For example, whereas psychodynamic traditions have historically
viewed the alliance as a direct mechanism of change, cognitive behavioral traditions have often
framed the alliance as a facilitative platform that allows other techniques (which are thought to be
the primary mechanisms) to have a greater effect on improvement (Zilcha-Mano, 2017). Thus, it
is possible that therapists who identify with different theoretical orientations may use the alliance
differently, owing to the framework that guides their practice. Similarly, although less commonly
discussed in the literature, with regard to OE, cognitive behavioral approaches arguably place

3

Although it was also of interest to know whether the between-therapist alliance-outcome and OE-outcome
associations varied among therapists, the nature of multilevel modeling precludes a direct test of this at the
highest level of analysis (in this case, the between-therapist level). Thus, the only way to examine whether
the therapist-level process-outcome association varied systematically based on other therapist-level
variables (i.e., moderation) was to test the significance of specific moderators (which, as discussed next in
the third aim, I did in this study).
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more emphasis on certain OE-related strategies (e.g., reviewing research support for a given
treatment; Constantino et al., 2018) than psychodynamic approaches. Consequently, given that
cognitive behavioral and psychodynamic traditions arguably hold the most distinct views of the
alliance (and possibly of OE), I focused on these two orientations in the present study.
Second, drawing on the aforementioned comments of researchers who have conducted
alliance-focused trainings (Crits-Christoph et al., 2010; Smith-Hansen, 2016), it is also plausible
that the degree to which therapists typically use interventions that focus on alliance (or OE) could
influence the extent to which these variables relate to those therapists’ outcomes. For example,
therapists who openly discuss the patient-therapist relationship may be better able to parlay the
alliance into symptom change. Similarly, therapists who report typically using OE-fostering
strategies (e.g., providing strong rationales for techniques) could be more aware of, and better
able to channel, patient OE to achieve better outcomes. Third, it is also possible that therapists are
somewhat aware of the extent to which they use the alliance and/or OE to achieve positive
outcomes. Thus, therapists’ own perceptions of their ability to effectively foster these factors
could moderate their associations with outcome. That is, therapists who subjectively believe they
are effectively alliance- or belief-centered may have stronger (or perhaps weaker) associations
between these process variables and their patients’ outcomes.
Finally, as an ancillary aim of this study, I examined the aforementioned possibility that
within- and between-therapist variability in alliance and OE could interact to influence treatment
outcome. In other words, the extent to which patient-level variability in alliance and OE
correlates with improvement could depend on therapists’ general abilities to foster positive
alliances and expectations across all patients in their caseloads. Although the only study of which
I am aware that tested this interaction found it to be nonsignificant (Baldwin et al., 2007), more
work is needed to determine if this complex effect exists in certain clinical contexts. Although
this interaction was a secondary, exploratory focus in this study, it bears noting that alternative
hypotheses are plausible.
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On the one hand, it could be that for generally “good” vs. “poor” alliance therapists (i.e.,
those with higher vs. lower quality average alliances across all patients in their caseload), patientlevel variability around the average has a more potent influence on treatment outcome. When
their alliance is higher than the average, it may mean that generally good alliance therapists are
better able to capitalize therapeutically on this higher-than-usual relational climate compared to
their generally poor alliance counterparts; however, when patients’ alliance is lower than the
typical quality, it may be more costly for the generally good vs. poor clinician (perhaps as a
function of cognitive dissonance from what is interpersonally familiar). On the other hand, it
could be that patient-level alliance variability is less strongly correlated with outcome for good
vs. poor alliance therapists. This alternate interaction might suggest that the therapists’ general
skill in fostering positive relationships renders each patient’s unique contribution to their alliance
less clinically influential, perhaps because the therapist’s typically positive contribution to the
relational climate establishes an alliance ceiling of sorts. These same possibilities would also
apply to the interactive effect of within- and between-therapist OE on outcome.
CHAPTER 2
METHOD
2.1 Dataset Overview
Data derived from a double-masked randomized trial that tested the efficacy of a
measurement-based patient-therapist Match System vs. case assignment as usual (CAU;
Constantino et al., 2021). Specifically, in the match condition, patients were assigned to therapists
who had empirical track records of effectiveness (based on the outcomes of at least 15 historical,
pretrial cases for each therapist) in treating the patient’s primary mental health problem(s). In the
CAU condition, patients were assigned to therapists through usual pragmatic means (e.g.,
therapist availability or location, therapist self-reported specialty). The trial took place within a
community mental health system in Cleveland, Ohio. As case assignment was the only
experimental manipulation, subsequent treatment was delivered naturalistically; thus, its length
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and nature varied by patient. For the purposes of the parent trial, “posttreatment” was considered
the point at which treatment terminated or after 16 weeks, whichever came sooner. In brief,
results indicated that patients in the match condition experienced significantly greater global
symptom reduction than patients in the CAU condition (d = 0.75). Given this between-group
effect, I included assignment condition as a covariate in all of the current analyses.
2.2 Participants
2.2.1 Therapists
Forty-eight therapists provided naturalistic treatment and were crossed between the match
and CAU conditions (to control for general between-therapist effects on outcome). Given the
present study’s focus on within- and between-therapist process-outcome associations, I included
the subsample of 42 therapists who treated more than one study patient (M = 5.05; range = 2 to
11). Importantly, the excluded therapists did not differ significantly from those in the present
subsample on any demographic or professional characteristics discussed next (all ps > .05). The
subsample therapists were mostly White (81%) and female (71%), and they held various
professional degrees: 69% had a master’s degree, 29% had a doctoral degree, and 2% had another
type of degree. The subsample therapists were on average 49.17 years old (SD = 13.81 years) and
had an average of 16.10 (SD = 11.74) years of post-licensure clinical experience. They endorsed a
variety of primary theoretical orientations, though 93% identified as at least “somewhat”
integrative. Regarding the extent to which therapists’ current practice was guided by different
theoretical frameworks (on a scale from 0 to 6, with 0 indicating not at all and 6 indicating very
much), subsample therapists identified most strongly with a “cognitive behavioral” orientation (n
= 42, M = 5.12, SD = 1.09), followed by “interpersonal” (n = 37, M = 3.92, SD = 1.48),
“humanistic/experiential” (n = 39, M = 3.31, SD = 1.69), “systems” (n = 36, M = 2.86, SD =
1.20), and “psychoanalytic/psychodynamic” (n = 37, M = 2.24, SD = 1.77).
2.2.2 Patients
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Two hundred eighteen adults were randomly assigned to either the scientific match (n =
99) or CAU (n = 119) condition. Only patients who were not the primary decision-maker for their
health care were excluded, resulting in a heterogenous sample with varied mental health
problems. Given the aforementioned methodological requirement that therapists treat multiple
study patients, the present subsample included the 212 patients (n = 98 match; n = 114 CAU) who
were treated by the 42 subsample therapists. The most common primary presenting problems
were: quality of life issues (21.2%), depression (19.8%), substance use (17.9%), and
panic/anxiety (9.9%). Table 1 shows patient demographic and clinical characteristics by
condition. Importantly, the excluded patients did not significantly differ from those in the present
subsample on any demographic or clinical characteristic (all ps > .05).
2.3 Treatment
As noted, psychotherapy was administered as usual. The parent trial capped data
collection at 16 weeks after the start of treatment, though therapy itself would have continued if
clinically indicated. Adjusted for the trial context, treatment lasted an average of 11.43 weeks (SD
= 6.09), and subsample patients attended an average of 5.67 (SD = 3.36) sessions. Finally, 21% of
subsample patients (n = 44) terminated treatment early (i.e., before session 3).
2.4 Measures
2.4.1 Mental Health
To assess domains of mental health, patients completed the Treatment Outcome Package
(TOP; Kraus et al., 2005; see Appendix A), a widely used routine outcome assessment tool. The
TOP consists of 58 items rated on a 6-point scale (ranging from 1-6) that assess 12
symptom/functioning domains: panic/somatic anxiety, depression, suicidal ideation, violence,
work functioning, sexual functioning, social conflict, substance use, sleep, mania, psychosis, and
quality of life. Based on a series of confirmatory factor analyses, the TOP has excellent factor
structure (Kraus et al., 2005). Moreover, with the exception of mania, the TOP subscales have
demonstrated good internal consistency, test-retest reliability, strong convergent validity with
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other well-established outcome measures, and sensitivity to clinical change (Kraus et al., 2005,
2011).4 Additionally, the TOP subscales can be summed to create an index of global
psychological distress/impairment (theoretical range of 58-348), with higher scores indicating
better functioning. Therefore, given this reverse scoring, the TOP total score is hereafter referred
to as global psychological well-being/functioning. This total score has demonstrated excellent
reliability, convergent validity with other measures of global symptom severity, and sensitivity to
clinical change (Kraus et al., 2005; Zack et al., 2015). In the present sample, the TOP total score
demonstrated good reliability throughout treatment (average Cronbach’s α = 0.85).
2.4.2 Alliance Quality
To assess alliance quality, patients completed the Working Alliance Inventory-Short
Form (WAI-S; Tracey & Kokotovic, 1989; see Appendix B), a widely used measure based on
Bordin’s (1979) tripartite conceptualization of the alliance as consisting of patient-therapist
agreement on treatment goals, agreement on treatment tasks, and emotional bond. The WAI-S
consists of 12 items rated on a 7-point scale (ranging from 1-7), with higher total scores reflecting
a better alliance (theoretical range of 12-84). The total score for the 36-item original WAI
(Horvath & Greenberg, 1989), from which the short-form derived, has excellent psychometric
properties (Elvins & Green, 2008). Similarly, most relevant to this study, the WAI-S total score
possesses excellent reliability and is highly correlated with the original measure (Tracey &
Kokotovic). In the present sample, the WAI-S total score demonstrated excellent reliability
throughout treatment (average Cronbach’s α = 0.96).
2.4.3 OE
To assess OE, patients completed the Credibility/Expectancy Questionnaire (CEQ;
Devilly & Borkovec, 2000; see Appendix C), a widely used belief measure. The OE subscale of
the CEQ consists of three face valid items: “By the end of the therapy period, how much

4

Despite the relatively poorer psychometric properties of the mania subscale (alphas ranging from .55 to
.70; test-retest ICC = .76), its influence on the psychometrics of the TOP total score is unproblematic.
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improvement in your presenting concerns/problems do you think will occur?” “At this point, how
much do you really feel that therapy will help you to reduce your presenting concerns/problems?”
and “By the end of the therapy period, how much improvement in your presenting
concerns/problems do you feel will occur?” The first and third OE items are measured on an 11point scale (ranging from 0-100% improvement in 10-point intervals), whereas the second is
measured on a 9-point scale (ranging from 1-9). Thus, prior to creating a total score for the OE
subscale, these items are rescaled to the same 9-point metric,5 with higher scores reflecting a
more positive outlook. The OE subscale of the CEQ has shown good internal consistency, testretest reliability, and predictive validity (Devilly & Borkovec). In the present sample, the OE
subscale demonstrated excellent reliability throughout treatment (average Cronbach’s α = 0.93).
2.4.4 Therapist Characteristics
To assess the relevant moderator variables, therapists completed study-specific measures
developed for the parent trial (Constantino et al., 2021). Specifically, therapists provided
information about their personal and professional characteristics via the Provider Characteristics
Form (PCF; see Appendix D). As reported previously, therapists rated the degree to which
various theoretical orientations influenced their practice (see Orlinsky & Rønnestad, 2005), and
my focus here was specifically on the psychoanalytic/psychodynamic (PA/PD) and cognitive
behavioral (CB) orientations. To assess therapists’ use of alliance- or OE-focused interventions, I
drew on items from an augmented version of the Comparative Psychotherapy Process Scale
(CPPS; Hilsenroth et al., 2005) for which therapists rated, from 0 (not at all) to 6 (very much),
“how characteristic” different interventions were of their “typical therapy practice.” For alliancefocused interventions, I used the following CPPS item: “Focus discussion on the relationship
between the clinician and client.” For OE-focused interventions, I used the following CPPS item:
“Explain the rationale behind your technique or approach to treatment.”

5

Importantly, despite this transformation, the original and rescaled items remain perfectly correlated.
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Therapists also completed the study-specific Therapist Perceived Strengths (TPS)
measure (see Appendix E). Relevant to this study, I drew on single items assessing therapists’
perceptions of their ability to effectively foster and maintain positive alliances and to cultivate
positive OE in their patients. Specifically, on a scale ranging from 1 (always more ineffective) to
7 (always more effective), therapists answered the following alliance/OE question: “Compared to
other clinicians, in establishing and maintaining a positive working alliance [instilling positive
outcomes expectations] with my clients, I would say that I am.”
2.5 Procedure
Therapists within the community mental health system were informed that the study
would examine various referral processes, but were kept unaware of the specific referral
manipulation. Consenting therapists completed a baseline survey packet that included the PCS
and TPS. Patients were recruited following naturalistic mental health care referrals. They were
informed that the study was examining various referral processes, and that both they and their
therapists would be unaware of the specific referral manipulation. Consenting patients completed
baseline study measures (including demographic and clinical information) and were then
randomized to condition (match vs. CAU).
Relevant to the present study, patients completed the TOP at baseline, after every odd
numbered week, and at posttreatment (as noted, either their actual final session or week 16 if they
remained in longer-term care). Patients also completed the WAI-S and CEQ after every evennumbered week. Given previous research suggesting that at least 4 occasions are required to
reliably assess a process variable (Crits-Christoph et al., 2011), I used the WAI-S and CEQ scores
across the first four measurement occasions as my primary predictor variables. To maintain
temporal precedence between the predictor and outcome variables, I used each patient’s
posttreatment TOP as the criterion variable. A University institutional review board approved the
parent trial and secondary analysis of deidentified data.
2.6 Data Analytic Plan
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I first examined descriptive statistics for the predictor, moderator, and outcome variables,
and transformed any variables that were not acceptably normally distributed (i.e., skewness value
of > + 2 or < -2). Next, to create the primary predictors, I took the average of the first four OE
and alliance measurements (typically at weeks 2, 4, 6, and 8).6 For the primary analyses, I used
multilevel structural equation modeling (MSEM; Preacher et al., 2010), as facilitated by the
Mplus 8.4 program (Muthén & Muthén, 1998–2017). Relevant to this study, MSEM is
advantageous because it automatically parses the predictor (alliance, OE) and outcome (global
psychological well-being/functioning) variables into their latent within- and between-therapist
components. This latent variable approach adjusts for measurement uncertainty, resulting in
unbiased within- and between-therapist estimates (Preacher et al., 2010).
Additionally, given that variance components and interactions (key foci of the present
study) are typically not normally distributed, I used the Bayesian estimator to generate 95%
credible intervals (CIs), which do not assume normality. Using this approach, 95% CIs that do not
contain zero are considered to be statistically significant (Muthén & Asparouhov, 2012).
Although this approach allows for the use of priors to inform model estimation, because I was
unaware of any previous studies testing therapist-level moderators of within- and betweentherapist process-outcome associations, I used non-informative priors (which allowed the model
to be estimated based on only the data). Additionally, because model convergence is not
guaranteed in Bayesian estimation, to verify the stability of significant results, I conducted postestimation diagnostics by forcing the relevant models to run longer estimation chains and
examining whether (a) the parameter estimates remained stable and (b) the proportional scale
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Although the study measures were distributed to patients at standardized intervals, there was some
variability in when patients completed the WAI and CEQ. On average, patients completed their first
process rating at 2.58 weeks (SD = 2.42), suggesting relatively strong compliance with the expected
measurement schedule. Additionally, across the four included measurement occasions, the average time in
weeks that patients completed the process measures was 5.11 (SD = 3.02), which is squarely in the middle
of the expected timeframe (i.e., weeks 2, 4, 6, and 8).
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reduction factor (the metric used to judge convergence in the Mplus program) remained low
across the additional iterations (i.e., between 1 and 1.1; Muthén, 2010).
All models were fit within a 2-level framework with within-therapist (between-patient)
differences at level 1 (i.e., differences between patients seen by the same therapist) and betweentherapist differences at level 2 (i.e., differences between therapists across all patients in their
caseloads). Additionally, missing data were handled using the Bayesian corollary of full
information maximum likelihood estimation. This method retains all participants who provide at
least one rating of a study variable, which resulted in all 42 therapists and 212 patients being
included in all analyses. Finally, effect sizes represent the average of the standardized
associations across clusters for each parameter (Asparouhov & Muthén, 2020).7 These
standardized associations can be interpreted similarly to partial correlation coefficients; that is,
the number of SDs of expected outcome change for every 1 SD change in the relevant predictor,
controlling for the effect of all other predictors.
To simultaneously test research aims 1 and 2, I fit two random slopes models (one for
each process variable predictor) testing the within- and between-therapist components of the
relevant process variable as predictors of within- and between-therapist outcome variance,
respectively. To test whether each within-therapist process-outcome association varied across
therapists, I allowed the relevant slope to be random and tested its significance. Thus, for each
process variable, the model yielded two primary fixed effect associations: (a) the within-therapist
process-outcome association (i.e., the extent to which differences in the relevant process among
different patients working with the same therapist related to differences in outcome among these
different patients working with the same therapist); and (b) the between-therapist processoutcome association (i.e., the extent to which differences in therapists’ average process levels
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This form of multilevel standardization is relatively new and has not yet been applied to some MSEM
models. Therefore, this form of standardization could not be validly applied to the fully between-therapist
interactions. Instead, the size of significant interactions for these models was determined by graphing the
relevant associations at different levels of the moderators (i.e., +/- 1 SD).
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across all patients in their caseloads related to differences in therapists’ average outcomes across
all patients in their caseloads). Additionally, as noted, each process model also yielded a random
effect that quantified the extent to which the within-therapist process-outcome association varied
across therapists (aim 2). See Appendix F for the full equation.
For research aim 3, I tested whether each relevant therapist-level variable (i.e., theoretical
orientation, self-reported use of alliance- or OE-focused interventions, and self-reported
perceptions of effectively using the alliance and OE during treatment) moderated the withintherapist process-outcome association (a cross-level interaction) and/or the between-therapist
process-outcome association (a fully therapist-level interaction). To preserve power and
parsimony, we fit with within- and between-therapist moderation models separately. However,
across both models, I controlled for the effect of the relevant process variable at the other level of
analysis (i.e., within or between).
The within-therapist moderation models were fit according to the random coefficient
prediction (RCP) model for testing cross-level interactions (Preacher et al., 2016). Specifically,
for each process variable, the relevant therapist-level moderators were included as level 2
predictors of the relevant within-therapist (level 1) process-outcome association. To enhance
interpretability of the intercept, the moderators were grand-mean centered. Additionally, for the
ancillary aim, this framework was also used to test whether between-therapist process variability
moderated the relevant within-therapist process-outcome association. The only difference for this
model was that the relevant between-therapist process variability was added as the moderator of
the within-therapist process-outcome association. Thus, across these models, I tested the extent to
which the within-therapist process-outcome association changed as a function of the betweentherapist level of the process. See Appendix G for the full equation.
The between-therapist moderation models were fit according to the latent moderated
structural equations (LMS) model for same-level interactions in MSEM (Asparouhov & Muthén,
2020; Preacher et al., 2016). This model involves the generation of latent interactions among
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random coefficients (in this case, the latent between-therapist component of the relevant process
variable and therapist-level moderator). Simulation research has shown that the LMS method
results in less bias than other multilevel moderation approaches (e.g., those using observed rather
than latent variables), including for sample sizes similar to the present study (Preacher et al.,
2016). However, given that this model is computationally complex (Preacher et al., 2016), and to
preserve power and model parsimony, I fit separate models for each moderator and treated the
sole continuous covariate of patient baseline global well-being/functioning as an observed (rather
than latent) variable. Therefore, I disaggregated this covariate into its within- and betweentherapist components using group-mean centering (Raudenbush & Bryk, 2002). The moderators
were grand-mean centered prior to the creation of the latent interactions. See Appendix H for the
full equation.
CHAPTER 3
RESULTS
3.1 Preliminary Analyses
As all study variables were acceptably normally distributed (all skewness values < +2 and
> -2), no transformations were needed. See Table 2 for descriptive statistics and intercorrelations
(i.e., total correlations) among all continuous study variables. In terms of missing patient data,
although all patients rated their baseline global well-being/functioning (N = 212), and all but 1
patient rated their posttreatment level of global well-being/functioning (n = 211),8 only 88% (n =
186) and 90% (n = 190) of patients provided alliance and OE ratings, respectively. In terms of
missing moderator data, all 42 therapists completed most items. However, 1 therapist did not
complete the following items: focus on the therapeutic relationship (i.e., “Focus discussion on the
relationship between the clinician and client”), focus on the therapy rationale (i.e., “Explain the

As noted, “posttreatment” in the parent trial referred to either 16 weeks or the point at which treatment
terminated, whichever came sooner. Therefore, even patients who terminated treatment early (e.g., before
session 3) could provide a posttreatment outcome assessment.
8
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rationale behind your technique or approach to treatment”). Additionally, 11.90% (n = 5) of
therapists did not complete the item assessing their identification with a
psychoanalytic/psychodynamic theoretical orientation. As noted, all missing data was handled
using the Bayesian version of FIML, which allowed all participants (patients and therapists) to be
retained in all analyses.
3.2 Within- and Between-Therapist Process-Outcome Associations
The full results of the 2-level MSEM model testing the within- and between-therapist
alliance-outcome associations are reported in Table 3 and visually depicted in Panel A of Figure
3. Most relevant to my research questions, although within-therapist fluctuations around a given
therapist’s mean level of alliance quality were unrelated to within-therapist differences in
patients’ posttreatment global well-being/functioning (within therapist association = 0.38; 95% CI
= -0.07, 0.75), therapists who fostered higher quality average alliances across all patients in their
caseloads tended to also achieve more patient improvement, on average (between-therapist
association = 0.62; 95% CI = 0.003, 1.10). Expressed as a standardized association, every 1-SD
increase in between-therapist alliance quality was associated with a .54-SD increase in average
patient posttreatment well-being/functioning.
Regarding OE, the full results of the 2-level MSEM model testing the within- and
between-therapist OE-outcome associations are reported in Table 4 and visually depicted in Panel
B of Figure 3. Most relevant to my research questions, at the within-therapist level, patients who
had more optimistic OE compared to their therapist’s mean level of OE also tended to experience
more posttreatment improvement than their therapist’s average patient (within therapist
association = 0.84; 95% CI = 0.15, 0.1.53). Expressed as a standardized association, every 1-SD
increase in within-therapist OE was associated with a .15-SD increase in patient posttreatment
well-being/functioning. In contrast, between-therapist differences in OE were unrelated to
caseload-level differences in patients’ global well-being/functioning (between-therapist
association = 2.64; 95% CI = -0.67, 6.20).
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3.3 Therapist-Level Variability in Within-Therapist Process-Outcome Associations
As hypothesized, random effects indicated that the within-therapist alliance-outcome
association varied significantly among therapists (11 = 0.40; 95% CI = 0.10, 1.33). Specifically,
therapists who were 1 SD above the mean had relatively strong, positive within-therapist allianceimprovement associations (simple slope = 1.01) that were more than double the average
association (average within-therapist association = 0.38), whereas therapists who were 1 SD
below the mean had relatively small, negative alliance-improvement associations (simple slope =
-.25). See Panel C of Figure 3 for a visual depiction.
Also as expected, random effects indicated that the within-therapist OE-outcome
association varied significantly across therapists (11 = 1.25; 95% CI = 0.36, 4.59). Specifically,
therapists who were 1 SD above the mean had strong, positive within-therapist OE-improvement
associations (simple slope = 1.96) that were more than double the average positive association
(average within-therapist association = 0.84), whereas therapists who were 1 SD below the mean
had slightly negative OE-improvement associations (simple slope = -.28). See Panel D of Figure
3 for a visual depiction.
3.4 Therapist-Level Moderation of the Within- and Between-Therapist Process-Outcome
Associations
The full results of the 2-level RCP MSEM model testing therapist-level moderators of the
within-therapist alliance-outcome association are reported in Model 1 of Table 5. Only therapist
self-perceived alliance-fostering ability significantly moderated the within-therapist allianceoutcome association (γ31 = -0.76; 95% CI = -1.18, -0.28). More specifically, whereas therapists
who perceived themselves as having above average (+1.5 SDs) abilities to foster high quality
alliances had negative (though only marginally significant) alliance-improvement associations
(simple slope = -0.57, one-tailed p = .04; 95% CI = -1.13, 0.14), therapists who perceived
themselves to have below average (-1.5 SDs) abilities to foster high quality alliances had strong
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positive alliance-improvement associations that were approximately 3 times larger than the
average within-therapist alliance-outcome association (simple slope = 1.14, one-tailed p = .001,
95% CI = 0.52, 1.72; see Figure 4). Regarding OE, the full results of the 2-level RCP MSEM
models testing therapist-level moderators of the within-therapist OE-outcome association are
reported in Model 2 of Table 5. None of the examined therapist-level variables significantly
moderated the within-therapist OE-improvement association.
Regarding the fully between-therapist moderation models, the full results of the alliance
and OE 2-level LMS MSEM models are reported in Table 6. Across these models, results
indicated that only the degree of CB theoretical orientation moderated the between-therapist
alliance-improvement association (γ04 = -0.46; 95% CI = -0.96, -0.004). As depicted in Figure 5,
for therapists with a more CB orientation (1 SD above the mean), the between-therapist allianceoutcome association was slightly negative (simple slope = -0.27; 95% CI = -0.82, 0.34). In
contrast, for therapists who reported a lower-than-average CB orientation (1 SD below the mean),
there was a strong positive between-therapist alliance-outcome association (simple slope = 0.75;
95% CI = 0.20, 1.37).9
3.5 Interactive Effect of Within- and Between-Therapist Variability in Process on Outcome
Finally, also using the RCP model reported above that tested therapist-level moderators
of the within-therapist alliance-outcome association, I examined whether between-therapist
differences in alliance and OE moderated the within-therapist alliance- and OE-outcome
associations, respectively. Results indicated that between-therapist differences in alliance quality

9

Because treatment length varied across patients, we replicated all models with research question-relevant
significant results (for aims 1, 2, and 3) with the total number of weeks patients were in the study as an
additional covariate. All significant alliance results (across all aims) remained statistically significant and
similarly sized. For OE, the within-patient OE-outcome association remained statistically significant and
similarly sized (the within-therapist element of aim 1), and the therapist-level variability in this association
also remained significant and similarly sized (aim 2). However, although the between-therapist OEoutcome association remained almost identical in size and total time in the study did not relate to outcome
at the therapist level, the OE-outcome association became only marginally significant when this additional
covariate was added (the therapist-level element of aim 1).
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did not moderate the within-therapist alliance-outcome association (γ31 = -0.03, SD = 0.04; 95%
CI = -0.13, 0.04). Similarly, there was also no evidence that between-therapist differences in OE
moderated the within-therapist OE-outcome association (γ31 = -0.26, SD = 7.01; 95% CI = 16.91,
14.82).
CHAPTER 4
DISCUSSION
The present study had three primary aims: (1) test the alliance- and OE-outcome
associations at both the within- and between-therapist levels; (2) examine whether the withintherapist alliance- and OE-outcome associations varied among therapists; and (3) explore
therapist-level moderators of the within- and between-therapist alliance- and OE-outcome
associations. Regarding aim 1, as hypothesized, both the alliance- and OE-outcome associations
were significant at either the within- or between-therapist level. More specifically, although
higher-quality between-therapist alliances associated with greater average improvement, withintherapist (between-patient) differences in alliance quality were unrelated to within-therapist
differences in improvement. In contrast, more optimistic OE was associated with greater
improvement at the within- but not between-therapist level. Regarding aim 2, as expected, the
within-therapist alliance-outcome association varied significantly among therapists, such that
some therapists had strong, positive alliance-improvement associations, others had negligible
alliance-improvement associations, and still others had negative alliance-improvement
associations. Similarly, the within-therapist OE-improvement association demonstrated
variability among therapists. Finally, regarding aim 3, therapists’ self-perceived alliance-fostering
ability and degree of CB orientation significantly moderated the within- and between-therapist
alliance-outcome associations, respectively. In contrast, no significant moderators of either the
within- or between-therapist OE-outcome associations emerged. This study also had one ancillary
aim: test whether the two components of the process-outcomes associations interacted to predict
treatment outcomes. For both alliance and OE, these interactions were not significant.
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The aim-1 finding that the between- but not within-therapist alliance-outcome association
was significant may help to clarify the presently mixed literature on this topic. Regarding the
between-therapist alliance-outcome association, out of now 10 studies to date, seven (including
the present one) have found a significant between-therapist alliance-improvement association
(i.e., Baldwin et al., 2007; Crits-Christoph et al., 2009; Crits-Christoph et al., 2018; Huppert et al.,
2014; Marcus et al., 2011; Zuroff et al., 2010), with only three finding a null association at this
level (i.e., Coyne et al., 2021; Crits-Christoph et al., 2011; Falkenström et al., 2014). Moreover,
the three studies that found a null between-therapist alliance-outcome association had design
features that could have limited the authors’ abilities to detect this relation. Specifically, two of
these studies only assessed the alliance at a single time point very early in treatment (e.g., session
1), making it more difficult to reliably capture therapists’ contributions to the alliance (CritsChristoph et al., 2011; Falkenström et al., 2014). The other study had a small number of
therapists, which resulted in low power (Coyne et al., 2021). Thus, the present results support a
growing consensus that therapists who consistently foster more positive alliances across all
patients in their caseload also tend to be more globally effective. In contrast, the within-therapist
alliance-outcome association can now be regarded as more mixed, with six studies finding a
significant alliance-improvement association (i.e., Coyne et al., 2021; Crits-Christoph, et al.,
2011; Falkenström et al., 2014; Huppert et al., 2014; Marcus et al., 2011; Zuroff et al., 2010) and
four (including the present one) finding a null association at this level (i.e., Baldwin et al., 2007;
Crits-Cristoph et al., 2009; Crits-Cristoph et al., 2018).
Clinically, these results may suggest that what is most consistently therapeutic about the
alliance is the portion that can be attributed to the therapist rather than the portion that can be
attributed to the patient or the specific patient-therapist pairing. Although speculative, this finding
may square with interpersonal theory positing that a quality alliance represents a novel and
corrective in-session relational experience that can generalize to patients’ extratherapy relational
functioning, which can, in turn, facilitate broader symptom reduction (e.g., Coyne et al., 2019;
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Zilcha-Mano, 2017). From this vantage point, it would make sense that the novel aspects of the
therapeutic relationship would be more attributable to what the therapist and overall treatment
context bring to the table than to what the patient imports, which could include a person’s
preexisting, relationship-fostering abilities and/or interpersonal problems (Zilcha-Mano).
Regardless of the reason, the present results further support the notion that therapists may wish to
monitor their general, caseload level alliances and engage alliance-focused trainings if their
average alliance levels tend to be lower than their peers. Of course, additional research is needed
to solidify further the between-therapist alliance-outcome association, and to continue to clarify
the within-therapist alliance-outcome association.
Regarding the aim-1 OE-outcome association, this study was the first to parse this
relation into its within- and between-therapist components. Therefore, there is no existing
literature with which to compare the present findings. Notably, though, in contrast to this study’s
alliance results, more optimistic OE was associated with greater improvement only at the withintherapist level. Although speculative, it seems plausible that in comparison to the inherently
interpersonal alliance construct, the patient-“owned” nature of the OE variable could render
individual, patient-level differences in this construct more potent for patient-level differences in
outcome (Constantino et al., 2018). In other words, it may make sense that this inherently patientfocused construct operates primarily at the patient-level of analysis. Thus, therapists might
consider monitoring their individual patients’ relative OE. When a particular patient reports lower
OE than usual, compared to the therapist’s other patients, then that therapist could consider
implementing OE-fostering strategies (e.g., providing personalized hope-inspiring statements,
tailoring treatment strategies to match a person’s beliefs; Constantino et al., 2018). Of course, the
presently novel multilevel OE-outcome findings, and their preliminary clinical implications,
require additional testing.
As expected, for aim 2, both the within-therapist alliance- and OE-outcome associations
varied significantly among therapists, providing proof of concept for the notion that different
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therapists may use different psychotherapy processes to differing therapeutic effects. Regarding
the alliance, this finding replicates the results of the limited previous research on this topic
(Coyne et al., 2021; Dinger et al., 2008) and extends this finding to naturalistic outpatient
settings. Together, these now three studies preliminarily suggest that one reason for the variability
in the size and significance of the within-therapist alliance-outcome association across studies
could be that therapists differ in the extent to which they effectively use the alliance to achieve
positive outcomes. Regarding OE, these results add nuance to the average within-therapist OEimprovement association revealed with aim 1 of this study; that is, there appears to be a subgroup
of therapists who do (those with strong, positive OE-improvement associations) and a subgroup
who do not (those with negative or negligible OE-improvement associations) need to closely
attend to differences in OE among the patients within their practices in order to maximize patient
improvement (or minimize harm).
Additionally, OE presents a special case for a process variable. Namely, given that it can
be assessed prior to the start of therapy (Constantino et al., 2018), the present results could
support a new form of patient-therapist matching; that is, because therapists with negative OEimprovement associations achieve better outcomes when patients report more vs. less pessimistic
OE, it could be beneficial to assign the subgroup of patients with low (more pessimistic)
presenting OE to these therapists. Similarly, it could also be beneficial to assign patients with
more positive/optimistic baseline OE to therapists who seem better able to capitalize on such
optimism (i.e., therapists with strong positive OE-improvement associations). Therefore, although
replication and further examination of specific moderators is needed (see my discussion of aim 3
below), these results preliminarily point to the importance of personalizing OE practice
recommendations and case assignments to the provider.
At least preliminarily, the present aim-3 results further extend the literature by pointing to
at least one therapist-level characteristic that can explain the previously discussed withintherapist alliance-outcome variability (i.e., significant therapist-level moderation). Specifically,
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whereas therapists who perceived themselves as having above average abilities to foster highquality alliances had negative alliance-improvement associations, therapists who perceived
themselves to have average or below average abilities to foster high-quality alliances had strong,
positive alliance-improvement associations that were approximately 3 times larger than the
average within-therapist alliance-outcome association. Therefore, for therapists who hold
humbler views of their relationship-fostering abilities, the alliance may represent a key ingredient
for fostering change in their patients, whereas those who view themselves as more
universally/consistently effective in building alliances may rely on other non-alliance processes
to affect change. Although the exact reason for such moderation remains unknown, I offer one
speculation.
It is plausible that the therapist self-perception variable is largely a byproduct of how they
view and use treatment processes. Those therapists using the alliance to the strongest effect may
also be the ones who see the variable as being at the core of their work. And with such a
relational focus, they may appreciate that alliance quality is neither always easily achieved nor
constant, which is reflected in what they may see as an accurate account of their abilities; that is,
regardless of their average relational skill, their alliances with individual patients will vary and
can sometimes be difficult/suboptimal. In contrast, those therapists whose alliances do not
associate strongly with outcome may also be the ones who place less emphasis on the alliance as
a central change agent. And with this secondary alliance focus, they may be less likely to perceive
or concern themselves with fluctuations in relational quality, which is reflected in what they may
see as an accurate account of their strong ability to cultivate a non-primary change process.
Regardless of the exact reason for this finding, it could have preliminary implications for
personalizing one’s practice to the factors that are most important for a given therapists’
outcomes – a therapist-level form of the “what works for whom” question. Specifically, it may be
helpful for therapists to “know thyself” by reflecting on their own comparative alliance-fostering
abilities. If therapists believe themselves to be roughly average compared to their peers (i.e.,
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“sometimes more effective” or “inconsistently more effective”), it may behoove them to closely
monitor their individual alliances with patients in the service of heightening effective responsivity
to this personally important variable. That is, when patients rate the alliance as high, it could be a
cue that things are going well and to continue with their treatment plan. In contrast, when the
alliance with a given patient is relatively low, it could be important to recognize this personal risk
factor for poorer outcomes and to respond accordingly (e.g., by incorporating explicit alliancefocused strategies; Flückiger et al., 2018).
In contrast, for therapists who do not have this level of the moderator, it could be less
clinically important for them to attend to within-caseload fluctuations in their alliances, as such
differences do not appear to be a key personal change agent. Of course, deriving more specific
implications for these therapists will depend on researchers and clinicians working together to
identify other (beyond the alliance) personalized change processes, which could be theoryspecific (e.g., effective use of cognitive interventions or interpretations) or theory-common (e.g.,
effective use of empathy, emotional expression). Alternatively, if such therapists were
nevertheless motivated to view and use the alliance as a change process, then they may benefit
from changing the present moderator; that is, becoming humbler about their alliance-fostering
abilities. However, future research will need to investigate whether/how such changes can
happen, and if they can indeed change the strength of a therapist’s alliance-outcome relation.
Finally, therapist identification with a CB orientation moderated the between-therapist
alliance-improvement association. Specifically, for strongly CB therapists, their caseload-level
average alliance quality was generally unrelated to their average outcomes. In contrast, for
therapists who did not identify with a CB orientation (or who identified with it less strongly than
their peers), their average alliance quality was a relatively strong positive predictor of their
average outcomes. This result squares with the theoretical role of the alliance in CB traditions;
that is, the alliance is historically viewed as a facilitative platform that allows other theoryspecific techniques (i.e., the more cognitive and behaviorally related putative change
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mechanisms) to have a greater effect on improvement (Castonguay et al., 2010; Hatcher &
Barends, 2006; Zilcha-Mano, 2017). Therefore, it seems plausible, and perhaps even likely, that
therapists who are strongly aligned with this theoretical perspective may place relatively less
emphasis on trying to parlay their alliances directly into patient improvement, which could
account for the observed null (and even slightly negative) between-therapist allianceimprovement association for these providers. It is worth noting that, somewhat counter to my
expectations, therapist identification with a PA/PD orientation did not have the opposite impact
on the between-therapist alliance-outcome association. Although speculative, this result could
owe to the fact that a strong identification with a PA/PD orientation was quite rare in this sample,
which could have limited my ability to detect this association. Alternatively, this result could
suggest that most of the other orientations (beyond CB) with which therapists in this sample
identified (e.g., interpersonal, humanistic) could place relatively equal emphasis on the alliance as
a change mechanism as compared with PA/PD. However, these speculations require additional
testing.
With additional regard to the CB moderator finding, though, it is worth reiterating that
this result does not imply that therapists of certain theoretical orientations tend to be globally
more vs. less effective. Instead, this result simply suggests that, for highly CB therapists, other
factors (beyond the alliance) are likely to explain between-therapist differences in outcome.
Therefore, it may be helpful for therapists to “know thyself” in terms of their degree of CB
orientation and to personalize their alliance practices accordingly. For example, it seems possible
that highly CB therapists may be most effective when they attend to the change processes that
they personally believe to be most facilitative of patient improvement (e.g., cognitive and
behavioral interventions). Notably, this idea is consistent with the anecdotal observations of CritsChristoph et al. (2010) who indicated that after an alliance-focused training, some therapists
appeared to become less effective, suggesting that a focus on this construct may have detracted
from their ability to implement the strategies that personally help them to work more effectively
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with their patients. When these anecdotal results are interpreted in the context of the present
findings, it seems likely that therapists’ degree of identification with a CB orientation could
represent one therapist-level characteristic that influences the efficacy of alliance-focused
trainings. Whereas therapists with a low or moderate degree of CB identification may be wise to
seek out alliance-focused trainings if/when their caseload-level alliances are relatively low in
quality, therapists with a strong CB orientation may be better served by seeking other types of
trainings to improve their outcomes. Of course, these speculations and preliminary training
implications require direct testing in future studies.
Overall, it is worth noting that several of the investigated therapist-level variables did not
moderate the alliance-outcome association at either level, and none explained variability in the
OE-outcome associations. Although this proof-of-concept study was largely exploratory, these
null results could have implications for future research. First, for both processes, the consistent
lack of moderation for therapists’ use of alliance- and OE-focused interventions could owe to the
present study’s reliance on self-report methods; that is, it is possible that therapists’ selfperceptions of their use of these strategies could be somewhat unrelated to their actual use of
such techniques. Therefore, it may be more fruitful for future studies to use observer-coding
methods that can capture therapists’ in-session provision, for example, of a compelling treatment
rationale (my putative OE-focused practice). Second, with specific regard to OE, the present
results may suggest that future therapist-level moderator research should look beyond the
variables investigated in the present study. For example, perhaps other OE-focused techniques
(such as providing personalized, hope-inspiring statements, tailoring treatment to a patient’s
momentary level of OE; Constantino et al., 2018) could allow therapists to parlay this belief into
symptom change.
Finally, across both alliance and OE, the ancillary aim demonstrated no evidence that
within- and between-therapist variability interacted to predict patient outcomes. Regarding the
alliance construct, this null finding actually replicates the results of the one previous study that
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tested this interaction (Baldwin et al., 2007). Although speculative, these results may suggest that
the behaviors/characteristics that allow therapists to capitalize on within-therapist alliance and OE
variability are fairly distinct from those that enable therapists to be more (or less) globally
effective at fostering these processes (i.e., the between-therapist components). If replicated, these
results would underscore the importance of disaggregating process-outcome correlations in order
to inform more nuanced clinical guidelines.
The present study had several limitations. First, as noted, I did not have access to session
recordings. Therefore, the assessments of all therapist-level moderators were based on self-report,
which could be subject to bias. Second, although based on existing measures, the therapist selfreport items were somewhat study-specific (Constantino et al., 2021). Third, despite this study
having a relatively large sample size compared to many psychotherapy process-outcome studies,
it only met the minimum sample size required to test multilevel moderation (Preacher et al.,
2016). Therefore, I cannot rule out the possibility that some of the null results observed for the
third aim could be a function of low power at the therapist level. Fourth, owing to the naturalistic
context, there was patient-level variability in the length of treatment, and relatedly, the number of
measurement occasions available for the process variables. Although a supplemental analysis
controlling for the number of weeks patients were in the study revealed generally consistent
results across the study aims, it remains that variable treatment lengths could have impacted the
study results, perhaps especially for OE. Thus, future research should replicate the present study’s
results in samples that include more consistent treatment lengths. Finally, the sample was mostly
White, with relatively high income; thus, replication is needed in more diverse samples.
Limitations notwithstanding, this study was one of the first to examine the potential
utility of personalizing psychotherapy process and training to the therapist. Using two common
processes, the results provided proof of concept for the idea that different therapists rely on
different psychotherapy processes to affect clinical change. Preliminarily, clinicians may wish to
attend to their own self-perceptions and theoretical orientations when attempting to parlay the
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alliance into therapeutic change. Additionally, if replicated, clinicians may use such information
to select personally well-suited clinical trainings, whether to embolden strengths or redress
weaknesses. Finally, the results also suggest that the time may be right for researchers to begin
attending to therapist-level “what works for whom” questions when examining both theoryspecific and common process-outcome associations, as such work has the potential to inform the
development of more nuanced personalized case assignments, clinical practices, and trainings that
take into account both participants in the psychotherapy endeavor.
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Table 1
Patient Baseline Demographic and Clinical Characteristics by Condition (N = 212)

Variables
Age
Sex
Female
Male
Race/ethnicity
Caucasian/White
Hispanic/Latino
African American/Black
Asian
Other
Sexual Orientation
Heterosexual
Bisexual
Gay or lesbian
Not sure
Missing
Annual Household Income
Less than 20,000
20,000-40,00
40,000-75,000
75,000-100,000
100,000 or more
Missing
Education
High school or less
Business or trade school
Two-year college
Four-year college
Masters or doctorate
Missing
Marital Status
Single
Married/cohabiting
Divorced/widowed/separated
Missing
Previous therapists/courses of therapya
On psychiatric medication?
Yes
No
Missingb
TOP-CS Total Scorec

M
34.44

1.72

CAU (n = 114)
SD
n (%)
11.67

M
33.09

Match (n = 98)
SD
n (%)
10.50

77 (67.5)
37 (32.5)

65 (66.3)
33 (33.7)

101 (88.6)
3 (2.6)
6 (5.3)
2 (1.8)
2 (1.8)

86 (87.8)
3 (3.1)
7 (7.1)
1 (1.0
1 (1.0)

92 (80.7)
10 (8.8)
4 (3.5)
5 (4.4)
3 (2.6)

88 (89.8)
6 (6.1)
3 (3.1)
0 (0.0)
1 (1.0)

6 (5.3)
11 (9.7)
36 (31.6)
21 (18.4)
37 (32.5)
3 (2.6)

7 (7.2)
10 (10.2)
28 (28.5)
24 (24.5)
28 (28.6)
1 (1.0)

14 (12.3)
6 (5.3)
10 (8.8)
41 (36.0)
33 (29.0)
10 (8.8)

18 (18.4)
8 (8.2)
13 (13.3)
29 (29.6)
22 (22.4)
8 (8.2)

53 (46.5)
51 (44.7)
7 (6.1)
3 (2.6)

45 (45.9)
43 (43.9)
9 (9.2)
1 (1.0)

1.89

1.56

1.51

34 (29.8)
55 (48.2)
25 (21.9)
258.03

26.57

26 (26.5)
52 (53.1)
20 (20.4)
252.87

29.13

Note. CAU = case assignment as usual; M = mean; SD = standard deviation; TOP-CS = Treatment
Outcome Package-Clinical Scales. a Note that n = 207 for this variable due to missing data. b The total
sample size for the psychiatric medication item is 167 because of a technological error during data
collection. c Note that n = 211 for this variable due to missing data.
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Table 2
Descriptive Statistics and Intercorrelations for All Continuous Study Variables
Variable

M

SD

1

2

3

4

5

6

7

8

9

1. Patient alliance
65.76
12.53
–
2. Patient OE
17.98
5.12
.71***
–
3. Baseline global well255.64
27.84
.06
.11
–
being/functioning
4. Posttreatment well273.55
27.07
.22**
.26***
.59***
–
being/functioning
5. Therapist CB
5.12
1.09
.02
.02
-.02
-.05
–
orientation
6. Therapist PA/PD
2.24
1.77
.05
.09
-.06
.06
-.20
–
orientation
7. Therapist focus on
2.56
1.45
.14
.03
-.01
.001
-.17
.38*
–
therapeutic relationship
8. Therapist self5.64
0.76
.09
.03
-.06
-.06
-.21
.34*
.26
–
perceived alliance
fostering ability
9. Therapist focus on
4.34
1.49
-.03
.08
-.05
.05
.42**
-.07
-.09
-.09
–
treatment rationale
10. Therapist self5.36
0.82
.04
.02
-.04
-.04
-.05
.30
.25
.72***
.20
perceived OE fostering
ability
Note. OE = outcome expectation; CB = cognitive-behavioral; PA/PD = psychoanalytic/psychodynamic. The significance values for some of these
correlations are inflated given that these correlations were estimated based on the raw data outside of a multilevel framework. Thus, the
intercorrelations are intended to provide purely descriptive information about the total correlation between each of our variables. Ns for correlations
involving patient-rated variables ranged from 180 to 211 and Ns for correlations involving only therapist-rated variables ranged from 36 to 42 due to
missing data.
*p < .05; **p < .01; ***p < .001
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Table 3
The Within- and Between-Therapist Alliance-Outcome Association (N = 212)
Fixed effects
Posttreatment TOP-CS, γ00
Baseline TOP-CSb, γ01
Allianceb, γ02
Match vs. control, γ10
Baseline TOP-CSw, γ20
Alliancew, γ30

Coefficient (SD)
154.25 (245.78)
0.31 (0.97)
0.62* (0.29)
7.06* (3.15)
0.59* (0.06)
0.38 (0.20)

95% CI
-492.85, 483.42
-1.08, 2.80
0.003, 1.10
1.39, 13.45
0.48, 0.70
-0.07, 0.75

ESa
--0.54
--b
0.60
0.13

Random effects
Level 1
Residual, σ2
Level 2

Coefficient (SD)

95% CI

ES

417.74* (45.27)

338.95, 511.38

--

22.75* (14.69)
6.21, 62.09
-Intercept, 00
Slope (within-therapist alliance-outcome
0.40* (0.32)
0.10, 1.33
-association), 11
-0.70 (1.89)
-4.14, 4.31
-Covariance (intercept with slope), 01
Note. CI = credible interval; ES = effect size; TOP-CS = Treatment Outcome Package-Clinical
Scales; b = between-therapist association; w = within-therapist association.
a
Effect sizes represent the average of the standardized associations across clusters for each
parameter.
b
Given that the assignment condition variable (match = 1, CAU = 0) is dichotomous, it does not
make sense to present the association as the expected outcome difference for a 1 SD change in the
predictor.
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Table 4
The Within- and Between-Therapist OE-Outcome Association (N = 212)
Fixed effects
Posttreatment TOP-CS, γ00
Baseline TOP-CSb, γ01
OEb, γ02
Match vs. control, γ10
Baseline TOP-CSw, γ20
OEw, γ30

Coefficient (SD)
100.56 (212.47)
0.47 (0.83)
2.64 (1.69)
7.84* (3.12)
0.58* (0.06)
0.84* (0.35)

95% CI
-435.33, 331.66
-0.43, 2.65
-0.67, 6.20
1.40, 13.48
0.46, 0.69
0.15, 1.53

ESa
-0.35
0.53
--b
0.59
0.15

Random effects
Level 1
Residual, σ2
Level 2

Coefficient (SD)

95% CI

ES

418.00* (45.48)

341.91, 520.02

--

24.71* (18.26)
3.78, 76.76
-Intercept, 00
Slope (within-therapist OE-outcome
1.25* (1.23)
0.36, 4.59
-association), 11
-2.31 (3.74)
-10.77, 4.43
-Covariance (intercept with slope), 01
Note. CI = credible interval; ES = effect size; TOP-CS = Treatment Outcome Package-Clinical
Scales; b = between-therapist association; OE = outcome expectation; w = within-therapist
association.
a
Effect sizes represent the average of the standardized associations across clusters for each
parameter.
b
Given that the assignment condition variable (match = 1, CAU = 0) is dichotomous, it does not
make sense to present the association as the expected outcome difference for a 1 SD change in the
predictor.
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Table 5
Moderators of the Within-Therapist Alliance- and OE-Outcome Association (N = 212)
Alliance Model

OE Model
95% CI

ESa

243.41,
301.62
-19.03, 16.75

--

0.09

Coefficient
(SD)
270.80*
(13.57)
0.57 (8.79)

0.21

-0.22, 1.29

0.45

1.40 (3.46)

-5.80, 6.26

0.23

-1.67 (1.45)

-4.62, 1.11

-0.21

-1.97 (1.93)

-5.65, 1.84

-0.27

PA/PD
orientation, γ04
Focus on
alliance/rationale, γ05
Self-perceived
alliance/OE fostering
ability
Match vs. CAU, γ10

2.30* (1.08)

0.13, 4.47

0.49

1.40 (1.10)

-0.76, 3.67

0.31

-0.20 (1.35)

-2.92, 2.33

-0.03

1.71 (1.55)

-1.25, 4.85

0.32

-3.88 (2.30)

-8.14, 1.03

-0.36

-1.55 (2.45)

-6.89, 3.01

-0.17

8.55* (2.70)

3.52, 13.89

--b

6.86* (2.92)

0.96, 12.32

--b

Baseline TOP-CSw,
γ20
Alliancew/OEw-TOPCS (slope), γ30
CB orientation, γ31

0.57* (0.06)

0.47, 0.68

0.58

0.57* (0.06)

0.46, 0.68

0.58

0.27 (0.17)

-0.01, 0.63

0.28

0.67 (0.42)

-0.17, 1.52

0.39

-0.04 (0.16)

-0.37, 0.28

-0.05

0.03 (0.38)

-0.71, 0.77

0.02

Fixed effects

a

Coefficient
(SD)
269.77*
(2.09)
0.27 (0.89)

95% CI

ES

265.60,
273.93
-2.73, 1.15

--

0.72 (0.39)

CB orientation, γ03

Posttreatment TOPCS, γ00
Baseline TOPCSb, γ01
Allianceb/OEb, γ02

PA/PD
-0.14 (0.13)
-0.34, 0.18
-0.26
-0.44 (0.25)
-1.01, 0.04
-0.50
orientation, γ32
Focus on
0.18 (0.13)
-0.09, 0.45
0.30
-0.09 (0.32)
-0.74, 0.49
-0.09
alliance/rationale, γ33
Self-perceived
-0.76*
-1.18, -0.28 -0.62
-0.03 (0.54)
-1.05, 1.08
-0.01
alliance/OE fostering
(0.24)
ability, γ34
Note. Coef. = coefficient; CI = credible interval; ES = effect size; TOP-CS = Treatment Outcome PackageClinical Scales; b = between-therapist association; OE = outcome expectation; CB = cognitive behavioral;
PA/PD = psychoanalytic/psychodynamic; w = within-therapist association.
*indicates that the 95% CI does not include zero.
a
Effect sizes represent the average of the standardized associations across clusters for each parameter.
b
Given that the assignment condition variable (match = 1, CAU = 0) is dichotomous, it does not make
sense to present the association as the expected outcome difference for a 1 SD change in the predictor.
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Table 6
Moderators of the Between-Therapist Alliance- and OE-Outcome Associations (N = 212)

CB orientation
Fixed effects
Posttreatment TOP-CS, γ00
Baseline TOP-CSb, γ01
Allianceb, γ02
Moderator, γ03
Interaction, γ04
Match vs. control, γ10
Baseline TOP-CSw, γ20
Alliancew, γ30

Coef. (SD)
173.73*
(36.49)
0.30* (0.14)
0.26 (0.16)
25.37* (11.90)
-0.46* (0.23)
2.34 (2.82)
0.61* (0.07)
0.24* (0.08)

95% CI
106.59,
246.05
0.06, 0.58
-0.06, 0.55
1.48,
49.29
-0.96,
-0.004
-3.14, 8.97
0.49, 0.75
0.08, 0.39

CB orientation

Alliance Models
PA/PD orientation
Coef. (SD)
177.30*
(43.12)
0.33 (0.17)
0.16 (0.20)
-3.02 (4.87)

95% CI
111.46,
278.06
-0.05, 0.57
-0.20, 0.46
-11.73,
6.45
0.06 (0.09)
-0.11,
0.25
2.92 (2.83)
-3.96, 8.04
0.61* (0.08) 0.44, 0.73
0.28* (0.09) 0.11, 0.46
OE Models
PA/PD orientation

Focus on alliance

0.01 (0.15)

95% CI
95.67,
245.51
0.03, 0.64
-0.22, 0.70
-18.90,
18.75
-0.33, 0.32

Self-perceived alliance
fostering ability
Coef. (SD)
95% CI
185.25*
121.84,
(36.18)
252.32
0.29* (0.14) 0.03, 0.51
0.19 (0.16)
-0.12, 0.47
-23.32
-50.97,
(15.48)
14.44
0.31 (.27)
-0.34, 0.82

2.35 (2.64)
0.61* (0.07)
0.26* (0.08)

-2.21, 8.15
0.48, 0.76
0.10, 0.42

2.23 (2.82)
0.61* (0.07)
0.24* (0.08)

Coef. (SD)
171.90*
(37.81)
0.33* (0.16)
0.24 (0.22)
-1.54 (8.49)

-3.24, 8.86
0.49, 0.75
0.08, 0.39

Focus on treatment
Self-perceived OE
rationale
fostering ability
Fixed effects
Coef. (SD)
95% CI
Coef. (SD)
95% CI
Coef. (SD)
95% CI
Coef. (SD)
95% CI
Posttreatment TOP-CS, γ00
175.11*
99.69,
174.66*
102.51,
180.87*
114.86,
191.41*
96.87,
(39.31)
255.04
(38.06)
244.18
(38.85)
262.99
(42.86)
267.96
Baseline TOP-CSb, γ01
0.33 (0.16)
-0.03, 0.63 0.33* (0.16) 0.03, 0.66 0.34* (0.15) 0.004, 0.58
0.30 (0.17)
-0.06, 0.66
OEb, γ02
0.70 (0.67)
-0.89, 1.79 0.70 (0.79)
-1.02, 2.40
0.44 (0.85)
-1.52, 2.02
0.34 (0.77)
-1.74, 1.74
Moderator, γ03
-6.65 (9.56)
-28.99,
8.13 (7.78)
-7.79,
1.48 (8.76)
-14.03,
2.52 (17.40)
-28.47,
11.08
19.42
17.20
43.09
Interaction, γ04
0.59 (0.63)
-0.78, 1.91 -0.54 (0.49) -1.25, 2.40 -0.09 (0.58) -1.03, 1.00
-0.27 (1.08) -2.64, 1.88
Match vs. control, γ10
3.05 (2.64)
-3.00, 6.89 2.52 (2.70)
-2.36, 8.23
2.38 (2.37)
-2.58, 6.63
2.08 (2.58)
-3.05, 6.99
Baseline TOP-CSw, γ20
0.61* (0.07)
0.49, 0.77 0.61* (0.07) 0.49, 0.77 0.62* (0.08) 0.46, 0.80
0.62* (0.08) 0.46, 0.75
OEw, γ30
0.45 (0.27)
-0.10, 0.96 0.45 (0.26)
-0.08, 0.99
0.53 (0.28)
-0.15, 0.97
0.43 (0.24)
-0.09, 0.84
Note. CB = cognitive-behavioral; PA/PD = psychoanalytic/psychodynamic; Coef. = coefficient; CI = credible interval; TOP-CS =
Treatment Outcome Package-Clinical Scales; OE = outcome expectation; b = between-therapist association; w = within-therapist
association.
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Figure 1. Hypothetical depiction of a significant, positive within-therapist process-improvement association and a nonsignificant betweentherapist process-improvement association. OE = outcome expectation.
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Figure 2. Hypothetical depiction of a nonsignificant within-therapist process-improvement association and a significant, positive betweentherapist process-improvement association. OE = outcome expectation.
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Figure 3. Average Within- and Between-Therapist Process-Outcome Associations and Variability in These Associations. Panel a depicts the sample
average within-therapist (standardized association = 0.13) and between-therapist (standardized association = 0.54) alliance-improvement association.
Panel b depicts the sample average within-therapist (standardized association = 0.15) and between-therapist (standardized association = 0.53) OEimprovement association. Panel c depicts variability in the within-therapist alliance-improvement association. Specifically, Therapist A’s data depicts a
negative within-therapist alliance-improvement association that is 1 SD below the mean. Therapist B’s data depicts the average within-therapist allianceimprovement association. In contrast, Therapist C’s data depicts a strong, positive within-therapist alliance-improvement association that is 1 SD above
the mean. Finally, panel d depicts variability in the within-therapist OE-improvement association. Specifically, Therapist A’s data depicts a strong,
positive within-therapist OE-improvement association that is 1 SD above the mean. Therapist B’s data depicts the average within-therapist OE-
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improvement association. In contrast, Therapist C’s data depicts a negative within-therapist OE-improvement association that is 1 SD below the mean.
Note. OE = outcome expectation.
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Figure 4. Self-perceived alliance-fostering effectiveness as a moderator of the within-therapist
alliance-improvement association. The dashed black line depicts the within-therapist allianceoutcome association for therapists who were 1.5 SDs below the mean level of self-perceived
alliance fostering effectiveness. The solid light grey line depicts the within-therapist allianceoutcome association for therapists with an average level of self-perceived alliance fostering
effectiveness. The solid dark grey line depicts the within-therapist alliance-outcome association
for therapists who were 1.5 SDs above the mean level of self-perceived alliance fostering
effectiveness.
Note. SP = self-perceived; eff. = effectiveness; TOP-CS = Treatment Outcome Package-Clinical
Scales.
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Figure 5. Degree of cognitive behavioral orientation as a moderator of the between-therapist
alliance-outcome association. The dashed black line depicts the between-therapist allianceoutcome association for therapists who reported a low level of cognitive behavioral orientation
(i.e., 1 SDs below the mean). The solid light grey line depicts the between-therapist allianceoutcome association for therapists with an average level of level of cognitive behavioral
orientation. The solid dark grey line depicts the between-therapist alliance-outcome association
for therapists who reported a high level of cognitive behavioral orientation (i.e., 1 SD above the
mean).
Note. TOP-CS = Treatment Outcome Package-Clinical Scale; CB = cognitive behavioral.
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TOP
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APPENDIX B
WAI – PATIENT VERSION
On the following pages there are some sentences that describe some of the different ways
a person might think or feel about his or her therapist (counselor). Please complete these ratings
in terms of your experience with your therapist during the most recent session. As you read the
sentences, mentally insert the name of your therapist (counselor) in place of the _________ in the
text.

1
Never

2
Rarely

3
4
Occasionally Sometimes

5
Often

6
Very Often

7
Always

Use the above seven point scale for each item. If the statement describes the way you
always feel (or think), circle the number ‘7’; if it never applies to you, circle the number ‘1’. Use
the numbers in between to describe the variations between these extremes. This questionnaire is
confidential; your therapist will not see your answers. Work fast; your first impressions are the
ones we would like to see. Please don’t forget to respond to every item.
______

1. __________ and I agree about the things I will need to do in therapy to help
improve my situation.

______

2. What I am doing in therapy gives me new ways of looking at my problem.

______

3. I believe __________ likes me.

______

4. __________ does not understand what I am trying to accomplish in therapy.

______

5. I am confident in _________’s ability to help me.

______

6. __________ and I are working on mutually agreed upon goals.

______

7. I feel that _________ appreciates me.

______

8. We agree on what is important for me to work on.

______

9. __________ and I trust one another.

______

10. __________ and I have different ideas on what my problems are.

______

11. We have established a good understanding of the kind of changes that would be
good for me.

______

12. I believe the way we are working with my problem is correct.
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APPENDIX C
CEQ – PATIENT VERSION
We would like you to indicate below how much you believe, right now, that the therapy
you are receiving will help to reduce your presenting concerns/problems. Belief usually
has two aspects to it: (1) what one thinks will happen and (2) what one feels will happen.
Sometimes these are similar; sometimes they are different. Please answer the questions
below. In the first set, answer in terms of what you think. In the second set, answer in
terms of what you really and truly feel.
Set I
1. At this point, how logical does the therapy offered to you seem?

1
2
not at all logical

3

4

5
6
7
8
9
somewhat
very
logical
logical
2. At this point, how successful do you think this treatment will be in reducing your
presenting concerns/problems?
1
2
not at all useful

3

4

1
2
not at all confident

3

4

5
6
7
8
9
somewhat
very useful
useful
3. How confident would you be in recommending this treatment to a friend who
experiences similar concerns/problems?
5
6
7
somewhat
confident
4. By the end of the therapy period, how much improvement in your
presenting concerns/problems do you think will occur?
0%

10%

20%

30%

40%

50%

60%

70%

80%

8

9
very
confident

90%

100%

Set II
For this set, close your eyes for a few moments, and try to identify what you really feel
about the therapy and its likely success. Then answer the following questions.
1. At this point, how much do you really feel that the therapy will help you
reduce your presenting concerns/problems?

1
2
not at all

3

4

5
somewhat

6

7

2. By the end of the therapy period, how much improvement in your
presenting concerns/problems do you really feel will occur?
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8

9
very much

0%

10%

20%

30%

40%

50%
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60%

70%

80%

90%

100%

APPENDIX D
PCF – THERAPIST-RATED
Date

_______

Provider TOP ID

_______

PART I: Demographic & Clinical Experiences
Current Age (enter in years):

_______

Gender (select applicable category):
Male
Female
Transgender

_______
_______
_______

Race/Ethnicity (select all that apply):
White/Caucasian
Hispanic
African American
Asian
Native American Indian
East Indian
Other
Other Description

_______
_______
_______
_______
_______
_______
_______
_______

Highest Current Degree:
Bachelor’s Degree
Master’s Degree (e.g., MA, MSW)
LMHC
Doctorate in Psychology (e.g., PhD, PsyD)
MD
Other
Other Description

_______
_______
_______
_______
_______
_______
_______

How many years have you been working as a clinician since you completed your highest
training/degree? _______
PART II: Orientation & Clinical Practices
How much is your current therapy practice guided by each of the following theoretical
frameworks?

Psychoanalytic/Psychodynamic
Cognitive-Behavioral
Humanistic/Experiential
Interpersonal
Systems

0=not at all
0
1
0
1
0
1
0
1
0
1
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2
2
2
2
2

3=somewhat
3
3
3
3
3

4
4
4
4
4

6=very much
5
6
5
6
5
6
5
6
5
6

Other (insert): _____________

0

1

2

3

4

5

6

To what extent do you currently regard yourself as having one primary orientation?
0=not at all
0
1

2

3=somewhat
3
4

6=very much
5
6

To what extent do you currently regard your orientation as Integrative?
0=not at all
0
1

2

3=somewhat
3
4

6=very much
5
6

Using the same 0-6 scale, please rate how characteristic each item is of your typical therapy
practice.
0=not at all
0
1

2

3=somewhat
3
4

6=very much
5
6

1. Encourage exploration of feelings regarded by the client as uncomfortable
(e.g., anger, fear, excitement, sadness, or happiness).

______

2. Give explicit advice or direct suggestions to the client.

______

3. Actively initiate the topics of discussion and therapeutic activities.

______

4. Link client’s current feelings or perceptions to experiences of the past.

______

5. Focus attention on similarities among the client’s relationship repeated
over time, settings, or people.

______

6. Focus discussion on the client’s irrational or illogical belief systems.

______

7. Focus discussion on the relationship between the clinician and client.

______

8. Encourage the client to experience and express feelings in the session.

______

9. Suggest specific activities/tasks (homework) for the client to attempt
outside sessions.

______

10. Address the client’s avoidance of important topics and shifts in mood.

______

11. Explain the rationale behind your technique or approach to treatment.

______

12. Focus discussion on the client’s future life situation.

______

13. Suggest alternative ways to understand experiences or events not
previously recognized by the client.

______

14. Identify recurrent patterns in the patient’s actions, feelings, and
experiences.

______

15. Provide client with information/facts about symptoms, disorder, or
treatment.

______
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16. Allow the client to initiate the discussion of significant issues, events,
or experiences.

______

17. Explicitly suggest that the client practice behavior learned in therapy
between sessions.

______

18. Teach the client specific techniques for coping with symptoms.

______

19. Encourage discussion of client’s wishes, fantasies, dreams, or early
childhood memories (positive or negative).

______

20. Interact with the client in a teacher-like (didactic) manner.

______

21. Encourage the client to recognize social influences on his/her experience.

______

22. Encourage the client to express feelings in symbolic or artistic forms.

______

23. Encourage the client to develop a spiritual mindset.

______

24. Encourage the client to develop a mindfulness mindset.

______

25. Other (describe):
__________________
26. Other (describe):
__________________
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APPENDIX E
TPS – THERAPIST-RATED
Date:
Provider TOP ID:

______
______

The following items ask you to provide ratings regarding your perceived therapeutic
effectiveness in specific domains. Some of these domains are symptom-specific, while
others are related to functioning and treatment process. Please use the following 1-7 scale:
1-Always ineffective
2-Usually ineffective
3-Sometimes ineffective
4-Inconsistently effective
5-Sometimes effective
6-Usually effective
7-Always effective
1. In treating my clients’ symptoms of DEPRESSION, I would say that I am:
______
2. In treating my clients’ symptoms of ANXIETY, I would say that I am:
______
3. In treating my clients’ symptoms of MANIA, I would say that I am:
______
4. In treating my clients’ symptoms of SUBSTANCE ABUSE, I would say that I am:
______
5. In treating my clients’ symptoms of PSYCHOSIS, I would say that I am:
______
6. In treating my clients’ SUICIDALITY, I would say that I am:
______
7. In reducing my clients’ risk of VIOLENCE, I would say that I am:
______
8. In improving my clients’ SEXUAL FUNCTIONING, I would say that I am:
______
9. In improving my clients’ SOCIAL FUNCTIONING, I would say that I am:
______
10. In improving my clients’ SLEEP, I would say that I am:
______
11. In improving my clients’ WORK FUNCTIONING, I would say that I am:
______
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12. In improving my clients’ QUALITY OF LIFE, I would say that I am:
______
13. In establishing and maintaining a positive WORKING ALLIANCE with my clients
I would say that I am:
______
14. In instilling POSITIVE OUTCOME EXPECTATIONS with my clients, I would say
that I am:
______
Please rank the following treatment domains in the order of your perceived relative
effectiveness, with a ranking of 1 indicating most effective relative to all other domains,
and 12 indicating least effective relative to all other domains:
______
______
______
______
______
______
______
______
______
______
______
______

DEPRESSION (reducing symptoms)
ANXIETY (reducing symptoms)
MANIA (reducing symptoms)
SUBSTANCE ABUSE (reducing symptoms)
PSYCHOSIS (reducing symptoms)
SUICIDALITY (reducing)
VIOLENCE (reducing risk)
SEXUAL FUNCTIONING (improving)
SOCIAL FUNCTIONING (improving)
SLEEP (improving)
WORK FUNCTIONING (improving)
OVERALL QUALITY OF LIFE (improving)

The following items ask you to provide ratings regarding your perceived therapeutic
effectiveness relative to other similarly trained and experienced clinicians in specific
domains. Some of these domains are symptom-specific, while others are related to
functioning and treatment process. Please use the following 1-7 scale:
1-Always more ineffective
2-Usually more ineffective
3-Sometimes more ineffective
4-Inconsistently more effective
5-Sometimes more effective
6-Usually more effective
7-Always more effective
1. Compared to other clinicians, in treating my clients’ symptoms of DEPRESSION,
I would say that I am:
______
2. Compared to other clinicians, in treating my clients’ symptoms of ANXIETY,
I would say that I am:
______
3. Compared to other clinicians, in treating my clients’ symptoms of MANIA,
I would say that I am:
______
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4. Compared to other clinicians, in treating my clients’ symptoms of SUBSTANCE
ABUSE, I would say that I am:
______
5. Compared to other clinicians, in treating my clients’ symptoms of PSYCHOSIS,
I would say that I am:
______
6. Compared to other clinicians, in reducing my clients’ SUICIDALITY, I would say
that I am:
______
7. Compared to other clinicians, in reducing my clients’ risk of VIOLENCE, I would
say that I am:
______
8. Compared to other clinicians, in improving my clients’ SEXUAL FUNCTIOING,
I would say that I am:
______
9. Compared to other clinicians, in improving my clients’ SOCIAL FUNCTIONING,
I would say that I am:
______
10. Compared to other clinicians, in improving my clients’ SLEEP, I would say that
I am:
______
11. Compared to other clinicians, in improving my clients’ WORK FUNCTIONING,
I would say that I am:
______
12. Compared to other clinicians, in improving my clients’ QUALITY OF LIFE, I would
say that I am:
______
13. Compared to other clinicians, in establishing and maintaining a positive WORKING
ALLIANCE with my clients, I would say that I am:
______
14. Compared to other clinicians, in instilling POSITIVE OUTCOME EXPECTATIONS
with my clients, I would say that I am:
______
Clinicians may have preferences for the types of clients with whom they would like to work.
The following is a list of characteristics that clients may possess. Please provide
preference ratings for each of the following client characteristic using the following 1-5
scale:
1-Strongly prefer not to work with this type of client
2-Somewhat prefer not to work with this type of client
3-No particular preference for this type of client (neither prefer nor do not prefer)
4-Somewhat prefer to work with this type of client
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5-Strongly prefer to work with this type of client
1. Problem Domains:
a. Depression
b. Anxiety
c. Substance abuse
d. Relationship problems
e. Psychosis
f. Sexual functioning
g. Mania
h. Violence
i. Suicide
j Sleep
k. Existential
l. Other (describe and rate)

______
______
______
______
______
______
______
______
______
______
______
______

2. Personality:
a. Extraverted
b. Introverted
c. Neurotic
d. Agreeable
e. Conscientiousness
f. Open to experience

______
______
______
______
______
______

3. Demographic:
a. Men
b. Women
c. Younger adults
d. Older adults
e. Religious/spiritual
f. Similar race/ethnicity (to your own)
g. Different race/ethnicity (from your own)

______
______
______
______
______
______
______

A variety of resources are available to clinicians that may assist in enhancing one’s
effectiveness. For the following list of potential resources, please provide a rating of (a)
how often you seek out this resource, and (b) how helpful you have found this resource in
enhancing your therapy practice:
Frequency Scale (1-5)

Helpfulness Scale (1-

1-Never Use/Seek This
2-Rarely Use/Seek This
3-Sometimes Use/Seek This
4-Often Seek/Use This

1-Not At All Helpful
2-Minimally Helpful
3-Somewhat Helpful
4-For the Most Part

5-Always Use/Seek This

5-Extremely Helpful

5)

Helpful

1. TOP Reports

Frequency

Helpfulness

______

______
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2. Journal Articles

______

______

3. Books

______

______

4. Peer Consultation

______

______

5. Supervision

______

______

6. Workshops

______

______

7. Other (describe and rate)

______

______

8. Other (describe and rate)

______

______

9. Other (describe and rate)

______

______

10. Other (describe and rate)

______

______
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APPENDIX F
WITHIN- AND BETWEEN-THERAPIST PROCESS-OUTCOME ASSOCIATION
EQUATION
Level-1 Model
Posttreatment TOP-CSij = β0j + β1j*(Within-therapist processij) + β2j*(Within-therapist baseline
TOP-CSij) + β3j*(Conditionij) + rij
Level-2 Model
β0j = γ00 + γ01*(Between-therapist baseline TOP-CSj) + γ02*(Between-therapist processj) + u0j
β1j = γ10 + u1j
β2j = γ20
β3j = γ30
At level 1, posttreatment global well-being/functioning for patient i seen by therapist j
was predicted by within-therapist differences in the relevant process variable (β1j), withintherapist differences in baseline global well-being/functioning (β2j), and condition (Match = 1;
CAU = 0; β3j). At level 2, the value of these parameters for each therapist (j) drop down to
become the outcome variables. Each therapist’s (j) average posttreatment global wellbeing/functioning across all patients in their caseload (adjusted for the level 1 covariates; β0j) was
predicted by between-therapist differences in their overall caseload severity at baseline (γ01) and
between-therapist differences in the relevant process variable (γ02). The remaining fixed effects
represent the average within-therapist process-outcome association (γ10), the average withintherapist baseline global well-being/functioning-outcome association (γ20), and the average effect
of case assignment condition (γ30). Random effects (u0j, u1j) allowed individual therapists to vary
around the sample averages and were allowed to covary. Importantly, u1j represents the extent to
which the within-therapist process-outcome association varies across therapists (i.e., the focus of
aim 2).
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APPENDIX G
RANDOM COEFFICIENT PREDICTION MODERATOR MODEL
Level-1 Model
Posttreatment TOP-CSij = β0j + β1j*(Within-therapist processij) + β2j*(Within-therapist baseline
TOP-CSij) + β3j*(Conditionij) + rij
Level-2 Model
β0j = γ00 + γ01*(Between-therapist baseline TOP-CSj) + γ02*(Between-therapist processj) +
γ03*(CB Orientationj) + γ04*(PA/PD Orientationj) + γ05*(Focus on alliance/rationale j) + γ06*(Selfperceived alliance/OE fostering effectiveness j) + u0j
β1j = γ10 + γ11*(CB Orientationj) + γ12*(PA/PD Orientationj) + γ13*(Focus on alliance/rationale j)
+ γ14*(Self-perceived alliance/OE fostering effectiveness j) + u1j
β2j = γ20
β3j = γ30
Most relevant to research aim 3, γ10 represents the within-therapist process-outcome
association for a therapist with an average level of the moderators (main effect), and γ11-γ14
represent the extent to which the within-therapist process-outcome association changes as a
function of each therapist-level moderator.
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APPENDIX H
LATENT MODERATED STRUCTURAL EQUATIONS MODEL
Level-1 Model
Posttreatment TOP-CSij = β0j + β1j*(Within-therapist processij) + β2j*(Within-therapist baseline
TOP-CSij) + β3j*(Conditionij) + rij
Level-2 Model
β0j = γ00 + γ01*(Between-therapist baseline TOP-CSj) + γ02*(Between-therapist processj) +
γ03*(Moderatorj) + γ04*(Latent between-therapist process by moderator interactionj) + u0j
β1j = γ10
β2j = γ20
β3j = γ30
Most relevant to research aim 3, γ02 represents the main effect of the relevant betweentherapist process for a therapist with an average level of the moderator, γ03 represents the main
effect of the moderator for a therapist with a score of zero on the relevant process variable, and γ03
represents the therapist-level interactive effect.
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